Document Type

Presentation

Publication Date

4-10-2013

Abstract

Cardiovascular disease (CVD) is an emerging problem in Sub-Saharan Africa. Many current guidelines recommend using global risk assessment (GRA) to quantify the risk for developing CVD and to guide treatment and policy. Most GRA tools require lipid measures which are not readily available in resource-constrained settings. Of the 3 most published non-laboratory based tools: Gaziano and Framingham substitute BMI for cholesterol; WHO does not include BMI or cholesterol.

Comments

Presented as part of the poster showcase at the Office of Community Partnerships' Community-Engaged Partnerships Symposium on April 10, 2013 at UMass Boston.

Share

COinS